HONG KONG — Based on the findings of advanced molecular simulations, Japanese researchers have proposed potent new curcumin derivatives for the inhibition of amyloid-beta (Abeta) peptides, the main causal agents of Alzheimer's disease (AD). The findings could lead to new treatments for AD and other diseases.